首页 > 市场调查报告书 > 医疗设备

病患监测体外诊断血糖监测

市场调查报告书

商品编码

1477937

连续血糖监测系统市场预测：~2032 年

Continuous Glucose Monitoring System Market Research Report Forecast till 2032

出版日期: 2024年04月30日 | 出版商:

Market Research Future | 英文 152 Pages | 订单完成后即时交付

价格

简介目录图表

在预测期内，连续血糖监测系统市场规模预计将以 11.24% 的复合年增长率成长。

糖尿病盛行率的增加是推动全球连续血糖监测系统市场成长的一个突出因素。患有糖尿病的人数正以惊人的速度增加，达到流行病的程度。根据全球糖尿病联盟 (IDF) 的数据，2021 年全球约有 5.37 亿人患有糖尿病，预计到 2030 年这一数字将跃升至 6.43 亿。此外，根据美国糖尿病协会的数据，到 2021 年，将有 3,840 万美国人（占总人口的 11.6%）患有糖尿病。 1 型糖尿病影响着约 200 万美国人，其中包括约 304,000 名儿童和青少年。随着糖尿病人口的持续增长，对有效的糖尿病管理解决方案的需求变得更加迫切。连续血糖监测系统在即时瞭解血糖水平方面发挥着至关重要的作用，使患者和医疗保健专业人员能够就治疗和生活方式的改变做出及时、明智的决定。连续血糖监测系统提供连续监测、早期异常检测和个人化见解的能力满足了不断增长的糖尿病族群的需求。

区域见解

北美连续血糖监测系统市场预计到 2023 年将达到 30.7 亿美元，在预测期内复合年增长率为 10.06%。

在技术进步和该地区糖尿病盛行率上升的推动下，北美的连续血糖监测系统市场正在经历强劲增长。

由于技术进步、医疗成本增加和糖尿病盛行率增加，欧洲连续血糖监测系统市场占据第二大市场。

由于患者人数众多、临床试验成本较低以及有利的监管政策，亚太地区连续血糖监测系统市场预计将在 2023 年至 2030 年期间成长最快。此外，各大公司积极向该地区扩张也推动了该地区的市场成长。

本报告调查了全球连续血糖监测系统市场，提供了市场的定义和概述，分析了影响市场成长的因素和市场机会、市场规模、各个细分市场/地区/主要的趋势和预测，它总结了细分：国家、竞争环境和主要公司概况。

The rising pervasiveness of diabetes overall stands apart as a conspicuous driver energizing the development of the worldwide continuous glucose monitoring systems market. Diabetes has arrived at plague extents, with a stunning ascent in the quantity of impacted people universally. As per the Global Diabetes Alliance (IDF), in 2021, roughly 537 million individuals overall were living with diabetes, and this number is supposed to take off to 643 million by 2030. Essentially, as per the American Diabetes Affiliation, diabetes impacted 38.4 million Americans, or 11.6% of the populace, in 2021. Type 1 diabetes influences around 2.0 million Americans, including roughly 304,000 youngsters and teenagers. The heightening rate of diabetes is ascribed to different elements, including stationary ways of life, unfortunate dietary propensities, and the maturing populace. As the diabetic populace keeps on developing, the interest for powerful diabetes the board arrangements turn out to be really squeezing. Continuous glucose monitoring systems assume a vital part in giving constant experiences into blood glucose levels, empowering patients and medical care experts to settle on convenient and informed choices in regard to therapy and way of life changes. The capacity of continuous glucose monitoring systems to offer continuous monitoring, early discovery of variances, and customized bits of knowledge lines up with the developing requirements of the extending diabetic populace.

Market Segmentation

Based on product the continuous glucose monitoring system market is divided into sensors and transmitter and receivers.

In terms of application, the market is classified into type 2 diabetes, type 1 diabetes, and non-diabetic patients.

Based on End user, the market has been divided into hospitals & clinics, homecare settings, and others.

Regional Insights

The North America continuous glucose monitoring systems market represented USD 3.07 billion out of 2023 and is projected to develop at a CAGR of 10.06% during the figure time frame. North America is additionally fragmented into the US, and Canada.

The North America continuous glucose monitoring systems market is encountering strong development, driven by mechanical progressions and a rising predominance of diabetes in the region.

Europe continuous glucose monitoring System market represented the second-biggest market share because of innovation progressions, expanding medical care consumption, and expanding pervasiveness of diabetes.

The Asia-Pacific Continuous Glucose Monitoring System market is supposed to be the quickest developing from 2023 to 2030 attributable to high persistent populace, decreased expenses of leading preliminaries, and good administrative arrangements. In addition, central participants working in the Continuous Glucose Monitoring System Market are effectively venturing into this region, further driving the regional market development.

Major Players

Key Companies operating in the Continuous Glucose Monitoring System market are Dexcom, Inc (US), Menarini Diagnostics Srl (Italy), Senseonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China).

1 MARKET INTRODUCTION

1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 OVERVIEW
2.2 DATA FLOW
- 2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE
2.4 SECONDARY SOURCES
- 2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
- 2.5.1 PRIMARY RESEARCH DATA FLOW:
- 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 2.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
- 2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA MODELING
- 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 2.8.2 DATA MODELING:
2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

3.1 INTRODUCTION
3.2 DRIVERS
- 3.2.1 INCREASING PREVALENCE OF DIABETES
- 3.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
- 3.2.3 INCREASING GERIATRIC POPULATION
3.3 RESTRAINTS
- 3.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
3.4 OPPORTUNITY
- 3.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

4 MARKET FACTOR ANALYSIS

4.1 VALUE CHAIN ANALYSIS
- 4.1.1 R&D
- 4.1.2 MANUFACTURING
- 4.1.3 DISTRIBUTION AND SALES
- 4.1.4 POST-SALES MONITORING
4.2 PORTER'S FIVE FORCES MODEL
- 4.2.1 THREAT OF NEW ENTRANTS
- 4.2.2 BARGAINING POWER OF SUPPLIERS
- 4.2.3 THREAT OF SUBSTITUTES
- 4.2.4 BARGAINING POWER OF BUYERS
- 4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS

MARKET

4.3.1 OVERVIEW

5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

5.1 OVERVIEW
5.2 SENSORS
5.3 TRANSMITTER & RECEIVERS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

6.1 OVERVIEW
6.2 TYPE DIABETES
6.3 TYPE DIABETES
6.4 NON-DIABETIC PATIENTS
- 6.4.1 WEIGHT LOSS
- 6.4.2 DIET MANAGEMENT
- 6.4.3 HEALTH & WELLNESS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 HOMECARE SETTINGS
7.4 OTHERS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

8.1 GLOBAL
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 SOUTH KOREA
- 8.4.5 AUSTRALIA
- 8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
- 8.5.1 MIDDLE EAST & AFRICA
- 8.5.2 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS,
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
- 9.6.2 AGREEMENT
- 9.6.3 PARTNERSHIP
- 9.6.4 COLLABORATION

10 COMPANY PROFILES

10.1 DEXCOM, INC
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 A. MENARINI DIAGNOSTICS SRL
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 KEY STRATEGIES
10.3 SENSEONICS
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 MEDTRUM TECHNOLOGIES INC.
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
10.5 NEMAURA MEDICAL INC
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGIES
10.6 ULTRAHUMAN HEALTHCARE PVT LTD
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
10.7 MEDTRONIC
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 ONE DROP
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
10.9 ABBOTT LABORATORIES, INC
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 SWOT ANALYSIS
- 10.9.6 KEY STRATEGIES
10.10 SINOCARE
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
10.11 NUTRISENSE
- 10.11.1 COMPANY OVERVIEW
- 10.11.2 FINANCIAL OVERVIEW
- 10.11.3 PRODUCTS OFFERED
- 10.11.4 KEY DEVELOPMENTS
- 10.11.5 KEY STRATEGIES
10.12 SUPERSAPIENS
- 10.12.1 COMPANY OVERVIEW
- 10.12.2 FINANCIAL OVERVIEW
- 10.12.3 PRODUCTS OFFERED
- 10.12.4 KEY DEVELOPMENTS
- 10.12.5 KEY STRATEGIES
10.13 SIGNOS INC.
- 10.13.1 COMPANY OVERVIEW
- 10.13.2 FINANCIAL OVERVIEW
- 10.13.3 PRODUCTS OFFERED
- 10.13.4 KEY DEVELOPMENTS
- 10.13.5 KEY STRATEGIES
10.14 LEVELS
- 10.14.1 COMPANY OVERVIEW
- 10.14.2 FINANCIAL OVERVIEW
- 10.14.3 PRODUCTS OFFERED
- 10.14.4 KEY DEVELOPMENTS
- 10.14.5 KEY STRATEGIES
10.15 VERI
- 10.15.1 COMPANY OVERVIEW
- 10.15.2 FINANCIAL OVERVIEW
- 10.15.3 PRODUCTS OFFERED
- 10.15.4 KEY DEVELOPMENTS
- 10.15.5 KEY STRATEGIES
10.16 LUMEN
- 10.16.1 COMPANY OVERVIEW
- 10.16.2 FINANCIAL OVERVIEW
- 10.16.3 PRODUCTS OFFERED
- 10.16.4 KEY DEVELOPMENTS
- 10.16.5 KEY STRATEGIES
10.17 JANUARY.AI
- 10.17.1 COMPANY OVERVIEW
- 10.17.2 FINANCIAL OVERVIEW
- 10.17.3 PRODUCTS OFFERED
- 10.17.4 KEY DEVELOPMENTS
- 10.17.5 KEY STRATEGIES

11 DATA CITATIONS

简介目录图表

LIST OF TABLES

TABLE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD BILLION)
TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD BILLION)
TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD BILLION)
TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD BILLION)
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD BILLION)
TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 17 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 22 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 26 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 30 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 39 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 47 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 51 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 64 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 68 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 72 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 76 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 80 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 84 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 88 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 89 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 93 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 97 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 101 PUBLIC PLAYERS STOCK SUMMARY
TABLE 102 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 103 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 104 AGREEMENT
TABLE 105 PERTNERSHIP
TABLE 106 COLLABORATION
TABLE 107 DEXCOM, INC: PRODUCT OFFERED
TABLE 108 DEXCOM, INC: KEY DEVELOPMENTS
TABLE 109 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
TABLE 110 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
TABLE 111 SENSEONICS: PRODUCT OFFERED
TABLE 112 SENSEONICS: KEY DEVELOPMENTS
TABLE 113 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
TABLE 114 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 115 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
TABLE 116 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
TABLE 117 MEDTRONIC: PRODUCTS OFFERED
TABLE 118 MEDTRONIC: KEY DEVELOPMENTS
TABLE 119 ONE DROP: PRODUCTS OFFERED
TABLE 120 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 121 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 122 SINOCARE: PRODUCTS OFFERED
TABLE 123 NUTRISENSE: PRODUCTS OFFERED
TABLE 124 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 125 SIGNOS INC.: PRODUCTS OFFERED
TABLE 126 LEVELS: PRODUCTS OFFERED
TABLE 127 VERI: PRODUCTS OFFERED
TABLE 128 LUMEN: PRODUCTS OFFERED
TABLE 129 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ONE DROP: SWOT ANALYSIS
FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS